Form 4: Vivani Medical Director Gregg Williams Increases Stake in Company

Director Gregg Williams reports multiple open market purchases of Vivani Medical (VANI) common stock, both directly and indirectly through various trusts and LLCs.

Summary

• Gregg Williams, a director and 10% owner of Vivani Medical, Inc. (VANI), has reported several transactions involving the company's common stock.
• On April 4, 2025, Williams directly purchased 34,000 shares at $0.99 and 5,600 shares at $0.98.
• On April 7, 2025, he directly purchased 44,400 shares at $0.99.
• Indirectly, through various trusts and LLCs, Williams acquired 58,583 shares on April 7, 2025, at $0.99 and 62,899 shares on April 8, 2025, at $1.02.
• Following these transactions, Williams directly owns 4,799,200 shares and indirectly owns 13,804,390 shares.
• The indirect holdings are through Gregg G. Williams 2006 Trust (11,678,638 shares), Williams International Co. LLC (1,212,856 shares), Sam Williams Family Investments LLC (181,587 shares), and Sam B. Williams 1995 Generation-Skipping Trust (731,309 shares).

Sentiment

Score: 7

Explanation: Insider buying is generally a positive sign, suggesting confidence in the company's future. However, it's just one data point and needs to be considered alongside other factors.

Positives

• A director increasing their stake in the company can be seen as a positive signal to investors.
• The purchases indicate confidence in the company's future prospects.

Industry Context

Insider buying is often viewed positively in the pharmaceutical industry, as it can signal confidence in the company's pipeline and future prospects.

Stakeholder Impact

• Shareholders may view the insider buying as a positive signal.
• The increased stake by a director could potentially influence company strategy.

Key Dates

Keywords

Vivani Medical, VANI, Gregg Williams, stock purchase, Form 4, director, beneficial ownership, insider trading